Fludeoxyglucose [F-18] Fdg Injection 0.5 Gbq (Fludeoxyglucose 18f SOLUTION) 0.5 GBQ

Fludeoxyglucose [F-18] FDG Injection 0.5 GBQ is a radiopharmaceutical solution used for diagnostic imaging. This intravenous injection aids in identifying metabolic activity in the body, often utilized in medical imaging procedures.

Strength

0.5 GBQ

Pack Size

LESS THAN 20ML

Manufacturer / TM Owner

THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fludeoxyglucose [F-18] FDG Injection is primarily used in positron emission tomography (PET) scans to evaluate metabolic processes. It helps in detecting areas of high glucose metabolism, which can be indicative of various conditions. This radiopharmaceutical is often employed in diagnostic imaging to assess the function of tissues and organs.

Side Effects

The effects of Fludeoxyglucose [F-18] FDG Injection are typically observed through imaging techniques. It highlights areas of increased metabolic activity, which can be visualized during a PET scan. This helps healthcare professionals in identifying and evaluating different medical conditions.

Precautions & Warnings

Handling Fludeoxyglucose [F-18] FDG Injection requires adherence to safety protocols due to its radioactive nature. It should be administered by trained professionals in a controlled environment. Proper disposal and containment measures must be followed to ensure safety.

Avoid Interactions

Fludeoxyglucose [F-18] FDG Injection may interact with certain medications or substances that affect glucose metabolism. It is important to inform healthcare providers about any medications being taken to avoid potential interactions. Always follow the guidance of a healthcare professional regarding the use of this radiopharmaceutical.

Frequently Asked Questions

Fludeoxyglucose [F-18] FDG Injection is used in PET scans to evaluate metabolic activity in the body, aiding in the diagnosis of various conditions.

This injection is administered intravenously by trained healthcare professionals in a controlled setting.

The effects are observed through imaging, highlighting areas of increased metabolic activity during a PET scan.

Yes, due to its radioactive nature, it should be handled and administered by trained professionals in a controlled environment.

It may interact with medications that affect glucose metabolism, so it's important to inform healthcare providers about any medications being taken.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.